These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6117842)

  • 61. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN
    Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A study on possible modulating and direct effects of gamma2-MSH and ACTH-(1-24) on the cardiovascular system of the rat.
    Van Bergen P; Vleeming W; Van Heijst BG; Versteeg DH; De Wildt DJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):220-9. PubMed ID: 9750008
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
    Kastin AJ; Hahn K; Banks WA; Zadina JE
    Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
    Zadina JE; Kastin AJ; Krieg EF; Coy DH
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin.
    Wilson JF
    Psychopharmacology (Berl); 1988; 96(2):262-6. PubMed ID: 2852821
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Functional state of the sympathetic-adrenal system in melanocyte-stimulating hormone deficiency under the effect of the melanocyte-inhibiting factor of the hypothalamus].
    Mel'nik BE; Robu AI; Paladiĭ ES
    Probl Endokrinol (Mosk); 1980; 26(2):57-60. PubMed ID: 6103533
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.
    Kastin AJ; Abel DA; Ehrensing RH; Coy DH; Graf MV
    Pharmacol Biochem Behav; 1984 Nov; 21(5):767-71. PubMed ID: 6151196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
    Miller LG; Kastin AJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1987 Dec; 28(4):521-4. PubMed ID: 2893390
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease.
    Voigt KH; Fehm HL; Lang RE; Beinert KE; Pfeiffer EF
    Horm Metab Res; 1977 Mar; 9(2):150-2. PubMed ID: 16818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MIF-1 and Tyr-MIF-1 fail to alter benzodiazepine-induced hypothermia.
    Kastin AJ; Miller LG; Schwartzenburg DS
    Pharmacol Biochem Behav; 1989 May; 33(1):261-3. PubMed ID: 2571169
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat.
    Bhargava HN; Ramarao P
    Peptides; 1989; 10(4):767-71. PubMed ID: 2573893
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of blockade of alpha 1-adrenoceptors, beta 1-adrenoceptors and vasopressin V1A receptors on the cardiovascular effects of gamma 2-melanocyte-stimulating hormone (gamma 2-MSH).
    Van Bergen P; De Winter TY; De Wildt DJ; Versteeg DH
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):720-6. PubMed ID: 9205956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aluminum alters the permeability of the blood-brain barrier to some non-peptides.
    Banks WA; Kastin AJ
    Neuropharmacology; 1985 May; 24(5):407-12. PubMed ID: 4022265
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
    Manberg PJ; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Permeability of the blood-brain barrier is not changed by vasoactive doses of arachidonic acid or prostaglandins in rats.
    Domer FR; Boertje SB; Sampson JB
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):27-37. PubMed ID: 3922022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats.
    Hayashi T; Kastin AJ; Coy DH; Olson RD
    Brain Res Bull; 1983 Dec; 11(6):659-62. PubMed ID: 6140994
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
    Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.